382 related articles for article (PubMed ID: 18636086)
1. The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response.
Friedman CS; O'Donnell MA; Legarda-Addison D; Ng A; Cárdenas WB; Yount JS; Moran TM; Basler CF; Komuro A; Horvath CM; Xavier R; Ting AT
EMBO Rep; 2008 Sep; 9(9):930-6. PubMed ID: 18636086
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of microRNA miR-526a by enterovirus inhibits RIG-I-dependent innate immune response.
Xu C; He X; Zheng Z; Zhang Z; Wei C; Guan K; Hou L; Zhang B; Zhu L; Cao Y; Zhang Y; Cao Y; Ma S; Wang P; Zhang P; Xu Q; Ling Y; Yang X; Zhong H
J Virol; 2014 Oct; 88(19):11356-68. PubMed ID: 25056901
[TBL] [Abstract][Full Text] [Related]
3. TRIM11 negatively regulates IFNβ production and antiviral activity by targeting TBK1.
Lee Y; Song B; Park C; Kwon KS
PLoS One; 2013; 8(5):e63255. PubMed ID: 23675467
[TBL] [Abstract][Full Text] [Related]
4. DDX3 directly regulates TRAF3 ubiquitination and acts as a scaffold to co-ordinate assembly of signalling complexes downstream from MAVS.
Gu L; Fullam A; McCormack N; Höhn Y; Schröder M
Biochem J; 2017 Feb; 474(4):571-587. PubMed ID: 27980081
[TBL] [Abstract][Full Text] [Related]
5. Regulation of IkappaB kinase-related kinases and antiviral responses by tumor suppressor CYLD.
Zhang M; Wu X; Lee AJ; Jin W; Chang M; Wright A; Imaizumi T; Sun SC
J Biol Chem; 2008 Jul; 283(27):18621-6. PubMed ID: 18467330
[TBL] [Abstract][Full Text] [Related]
6. Negative role of RIG-I serine 8 phosphorylation in the regulation of interferon-beta production.
Nistal-Villán E; Gack MU; Martínez-Delgado G; Maharaj NP; Inn KS; Yang H; Wang R; Aggarwal AK; Jung JU; García-Sastre A
J Biol Chem; 2010 Jun; 285(26):20252-61. PubMed ID: 20406818
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING signaling pathways.
Han L; Zhuang MW; Deng J; Zheng Y; Zhang J; Nan ML; Zhang XJ; Gao C; Wang PH
J Med Virol; 2021 Sep; 93(9):5376-5389. PubMed ID: 33913550
[TBL] [Abstract][Full Text] [Related]
8. DDX60, a DEXD/H box helicase, is a novel antiviral factor promoting RIG-I-like receptor-mediated signaling.
Miyashita M; Oshiumi H; Matsumoto M; Seya T
Mol Cell Biol; 2011 Sep; 31(18):3802-19. PubMed ID: 21791617
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of inhibiting type I interferon induction by hepatitis B virus X protein.
Jiang J; Tang H
Protein Cell; 2010 Dec; 1(12):1106-17. PubMed ID: 21213104
[TBL] [Abstract][Full Text] [Related]
10. Arenavirus nucleoprotein targets interferon regulatory factor-activating kinase IKKε.
Pythoud C; Rodrigo WW; Pasqual G; Rothenberger S; Martínez-Sobrido L; de la Torre JC; Kunz S
J Virol; 2012 Aug; 86(15):7728-38. PubMed ID: 22532683
[TBL] [Abstract][Full Text] [Related]
11. DEAD/H BOX 3 (DDX3) helicase binds the RIG-I adaptor IPS-1 to up-regulate IFN-beta-inducing potential.
Oshiumi H; Sakai K; Matsumoto M; Seya T
Eur J Immunol; 2010 Apr; 40(4):940-8. PubMed ID: 20127681
[TBL] [Abstract][Full Text] [Related]
12. Phosphatidylinositol-3-kinase and Akt are required for RIG-I-mediated anti-viral signalling through cross-talk with IPS-1.
Yeon SH; Song MJ; Kang HR; Lee JY
Immunology; 2015 Feb; 144(2):312-20. PubMed ID: 25158146
[TBL] [Abstract][Full Text] [Related]
13. Restoration of the activated Rig-I pathway in hepatitis C virus (HCV) replicon cells by HCV protease, polymerase, and NS5A inhibitors in vitro at clinically relevant concentrations.
Kalkeri G; Lin C; Gopilan J; Sloan K; Rijnbrand R; Kwong AD
Antimicrob Agents Chemother; 2013 Sep; 57(9):4417-26. PubMed ID: 23836176
[TBL] [Abstract][Full Text] [Related]
14. Ataxia telangiectasia mutated kinase mediates NF-κB serine 276 phosphorylation and interferon expression via the IRF7-RIG-I amplification loop in paramyxovirus infection.
Fang L; Choudhary S; Tian B; Boldogh I; Yang C; Ivanciuc T; Ma Y; Garofalo RP; Brasier AR
J Virol; 2015 Mar; 89(5):2628-42. PubMed ID: 25520509
[TBL] [Abstract][Full Text] [Related]
15. RACK1 attenuates RLR antiviral signaling by targeting VISA-TRAF complexes.
Xie T; Chen T; Li C; Wang W; Cao L; Rao H; Yang Q; Shu HB; Xu LG
Biochem Biophys Res Commun; 2019 Jan; 508(3):667-674. PubMed ID: 30527812
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus.
Mibayashi M; Martínez-Sobrido L; Loo YM; Cárdenas WB; Gale M; García-Sastre A
J Virol; 2007 Jan; 81(2):514-24. PubMed ID: 17079289
[TBL] [Abstract][Full Text] [Related]
17. A Src-family-tyrosine kinase, Lyn, is required for efficient IFN-β expression in pattern recognition receptor, RIG-I, signal pathway by interacting with IPS-1.
Lim YJ; Koo JE; Hong EH; Park ZY; Lim KM; Bae ON; Lee JY
Cytokine; 2015 Mar; 72(1):63-70. PubMed ID: 25585356
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus polymerase inhibits RIG-I- and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKKepsilon and DDX3.
Yu S; Chen J; Wu M; Chen H; Kato N; Yuan Z
J Gen Virol; 2010 Aug; 91(Pt 8):2080-2090. PubMed ID: 20375222
[TBL] [Abstract][Full Text] [Related]
19. TRAF5 is a downstream target of MAVS in antiviral innate immune signaling.
Tang ED; Wang CY
PLoS One; 2010 Feb; 5(2):e9172. PubMed ID: 20161788
[TBL] [Abstract][Full Text] [Related]
20. Human kinome analysis reveals novel kinases contributing to virus infection and retinoic-acid inducible gene I-induced type I and type III IFN gene expression.
Nousiainen L; Sillanpää M; Jiang M; Thompson J; Taipale J; Julkunen I
Innate Immun; 2013 Oct; 19(5):516-30. PubMed ID: 23405030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
